Literature DB >> 2657619

Epidemiology of invasive Haemophilus influenzae type b disease among children in Finland before vaccination with Haemophilus influenzae type b conjugate vaccine.

A K Takala1, J Eskola, H Peltola, P H Mäkelä.   

Abstract

On the basis of intensified surveillance in Finland we report the epidemiology of invasive Haemophilus influenzae type b disease based on 333 consecutive culture-proved cases recorded during 1985 and 1986. The annual incidence rate among children younger than 5 years of age was 52/100,000; 46% of patients had meningitis, 29% had epiglottitis and 25% had other forms of invasive disease. The median age of patients was 27 months, with 45% younger than 2 years of age. Meningitis and epiglottitis were found more often among boys than among girls, whereas the opposite was found among patients with other types of invasive disease (P = 0.015). Among the latter 68% of children with pneumonia or septicemia were 2 years or older compared with 32% of patients with arthritis, cellulitis or pyelonephritis (P = 0.009). These background data are essential for correct interpretation and application of results from trials with H. influenzae type b conjugate vaccines that are currently ongoing in Finland.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2657619

Source DB:  PubMed          Journal:  Pediatr Infect Dis J        ISSN: 0891-3668            Impact factor:   2.129


  16 in total

1.  Outer membrane protein subtypes of Haemophilus influenzae type b isolates causing invasive disease in Victoria, Australia, from 1988 to 1990.

Authors:  D A Clements; S J MacInnes; G L Gilbert
Journal:  J Clin Microbiol       Date:  1992-07       Impact factor: 5.948

2.  Cost-effectiveness of Haemophilus influenzae type b conjugate vaccine in low- and middle-income countries: regional analysis and assessment of major determinants.

Authors:  Ulla Kou Griffiths; Andrew Clark; Rana Hajjeh
Journal:  J Pediatr       Date:  2013-07       Impact factor: 4.406

Review 3.  Cost of treatment and prevention of Haemophilus influenzae type b disease. An international perspective.

Authors:  D A Clements
Journal:  Pharmacoeconomics       Date:  1994-11       Impact factor: 4.981

4.  Different seroprevalences of antibodies against Neisseria meningitidis serogroup A and Haemophilus influenzae type b in Sudanese and Swedish children.

Authors:  M A Salih; H Fredlund; S Hugosson; L Bodin; P Olcén
Journal:  Epidemiol Infect       Date:  1993-04       Impact factor: 2.451

5.  Incidence of invasive Haemophilus influenzae type b disease in Italian children.

Authors:  A E Tozzi; S Salmaso; M L Ciofi degli Atti; P Panei; A Anemona; G Scuderi; S G Wassilak
Journal:  Eur J Epidemiol       Date:  1997-01       Impact factor: 8.082

Review 6.  Cost-benefit analysis of a Haemophilus influenzae type b meningitis prevention programme in The Philippines.

Authors:  M R Limcangco; C L Armour; E G Salole; S J Taylor
Journal:  Pharmacoeconomics       Date:  2001       Impact factor: 4.981

7.  Incidence and etiological agents of bacterial meningitis among children <5 years of age in two districts of Romania.

Authors:  V Luca; B D Gessner; C Luca; T Turcu; S Rugina; C Rugina; M Ilie; E Novakova; C Vlasich
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2004-06-26       Impact factor: 3.267

8.  Invasive Haemophilus influenzae type b disease in the Oxford region (1985-91).

Authors:  R Booy; S A Hodgson; M P Slack; E C Anderson; R T Mayon-White; E R Moxon
Journal:  Arch Dis Child       Date:  1993-08       Impact factor: 3.791

9.  Antibodies to Haemophilus influenzae type b outer membrane proteins in children with epiglottitis or meningitis and in healthy controls.

Authors:  P D Johnson; S J MacInnes; G L Gilbert
Journal:  Infect Immun       Date:  1993-04       Impact factor: 3.441

10.  Epidemiology of Haemophilus influenzae type b invasive disease in Wales.

Authors:  A J Howard; K T Dunkin; J M Musser; S R Palmer
Journal:  BMJ       Date:  1991-08-24
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.